New COVID-19 Vaccine Developed in Australia is Safe for Humans - Experts Claim    

As most of the countries are going ahead with COVID-19 vaccine trial, a new potential COVID-19 vaccine has been developed in Australia that has shown positive results in human clinical trials. 

As per experts, the vaccine candidate has shown zero side effects in human trials and has also shown promising results when tried on animals.

According to a DailyMail report, the University of Queensland (UQ) and Australian biotech giant CSL began the trial with injecting 120 Brisbane volunteers with the potential shot against the novel coronavirus infection earlier in July. Project co-leader Associate Professor Keith Chappell said after the first trial doses were administered on animals, it was successful.

Giving a further update on the vaccine, Dr Chappell was quoted saying, "The UQ vaccine, which uses what is known as molecular clamp technology, created the neutralising immune response in animal models, which was better than the average level of antibodies found in patients who have recovered from COVID-19." 

Meanwhile, the UQ team gave doses of the vaccine to the animals and then exposed them to coronavirus to see whether the drug provoked the desired immune response.

As per a report from the experts, the hamster models, states that the vaccine combined with the Seqirus MF59® adjuvant, provided protection against virus replication, and reduced lung inflammation following exposure to the novel coronavirus. None of the 120 human participants who received a single vaccine dose experienced any negative side effects.

The UQ's Brisbane project is one of just 17 human trials for a potential COVID-19 vaccine which is undergoing worldwide. Earlier on August 19, CSL Ltd had raised hopes of delivering a coronavirus vaccine within a year, DailyMail further reports.